RecruitingNCT05981300
GpCRC Pediatric Gastroparesis Registry 2
GpCRC Pediatric Gastroparesis Registry 2: Characterization and Clinical Course of Symptoms and Gastric Emptying in Pediatric, Adolescent, and Young Adult Participants With Symptoms of Gastroparesis
Sponsor
Johns Hopkins Bloomberg School of Public Health
Enrollment
216 participants
Start Date
Dec 18, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
The objective of the Pediatric Gastroparesis Registry 2 is to create a national prospective registry of children, adolescents, and young adults with gastroparesis and gastroparesis-like syndrome (symptoms of gastroparesis but normal gastric emptying).
Eligibility
Min Age: 8 YearsMax Age: 25 Years
Inclusion Criteria9
- Provision of signed and dated informed consent form and assent, as age appropriate.
- Stated willingness to comply with all study procedures and availability for the duration of the study
- to 25 years of age at the time of enrollment
- Symptoms of Gp of at least 12 weeks duration: constellation of some combination of:
- nausea, vomiting, early satiety, postprandial fullness; symptoms sometimes may be accompanied by upper abdominal pain
- Have undergone a gastric emptying scintigraphic study of solids using 4-hour Egg Beaters protocol (or equivalent generic liquid egg white meal) within the last 12 months who fall into one of the two categories:
- Delayed gastric emptying-defined as an abnormal 2-hour (\>60% retention) and/or 4- hour (\>10% retention) result based on a 4-hour scintigraphic gastric emptying study
- Gastric emptying that is not delayed but who have symptoms of Gp (designated in this study as GLS) or have previously participated in the Pediatric Gastroparesis Registry (PGpR) study
- An etiology of either diabetic or idiopathic Gp or GLS
Exclusion Criteria18
- Inability to comply with or complete the scintigraphic gastric emptying test (including allergy to eggs)
- Pregnancy
- Autism spectrum disorder, significant developmental delay, psychosis (because of inability to complete questionnaires)
- Use of narcotic analgesics greater than three days per week.
- Presence of conditions associated with GI mucosal disease (e.g., inflammatory bowel disease, known eosinophilic gastroenteritis or eosinophilic esophagitis, gastric ulcer, peptic ulcer, celiac disease)
- Presence of any other condition that could case delayed gastric emptying
- Gastrointestinal construction confirmed by upper endoscopy (EGD), upper gastrointestinal series (UGI), or abdominal CT
- Primary neurological conditions that can cause nausea and vomiting such as increased intracranial pressure, space occupying or inflammatory/infectious legions
- Acute or chronic renal failure (abnormal creatinine for age) and /or on hemodialysis or peritoneal dialysis
- Acute liver failure
- Advanced liver disease (features of portal hypertension)
- Clinically significant congenital heart disease (i.e., vaginal injury during cardiac repair)
- History of esophageal, gastric or bowel surgery.
- Metabolic disease including mitochondrial disease and inborn errors of metabolism
- Chronic lung disease (including cystic fibrosis)
- A serious chronic medical condition (e.g., inflammatory bowel disease)
- Use of medications that can affect motility during the gastric emptying study
- Any other condition, which in the option of the investigator, could explain the symptoms or could interfere with study requirements.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(6)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05981300
Related Trials
Gastroparesis Registry 4
NCT058468026 locations
Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms
NCT046612155 locations
Study of Gastric Motility in Eosinophilic Gastritis
NCT052294323 locations
Compassionate Use of Domperidone for Refractory Gastroparesis
NCT046995911 location
Development and Validation of a Risk Prediction Model for Gastric Retention in Patients Undergoing Sedated Gastroscopy
NCT071042143 locations